This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Tempus Ai, Inc., Tempus Labs, Inc.. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Jerod Parsons: Innovator in Cancer Treatment Technologies
Introduction
Jerod Parsons is a notable inventor based in Chicago, IL, who has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on improving cancer treatment predictions and outcomes, particularly through the use of machine learning technologies.
Latest Patents
Jerod holds a patent for an "Integrated machine-learning framework to estimate homologous recombination deficiency." This patent encompasses methods, systems, and software designed to determine the homologous recombination pathway status of cancer in test subjects. The framework aims to enhance the accuracy of cancer treatment predictions by utilizing various classifiers, including measures of DNA damage repair genes and tumor sample purity.
Career Highlights
Jerod Parsons is currently employed at Tempus Labs, Inc., a company dedicated to advancing precision medicine through data-driven insights. His work at Tempus Labs allows him to apply his innovative ideas in a practical setting, contributing to the development of advanced cancer treatment methodologies.
Collaborations
Jerod collaborates with talented professionals in his field, including Aarti Venkat and Joshua S K Bell. These collaborations foster a dynamic environment for innovation and research, enhancing the potential impact of their collective work.
Conclusion
Jerod Parsons exemplifies the spirit of innovation in the medical field, particularly in cancer treatment technologies. His contributions through patents and collaborative efforts are paving the way for improved patient outcomes and more effective treatment strategies.